Despite investing months rolling out MEDDIC, many organizations soon discover that forecast accuracy and deal wins don't improve as much as they'd hoped.
Few sales methodologies have become as synonymous with enterprise selling as MEDDIC.
For decades, sales organizations have adopted the framework to improve qualification, increase forecast accuracy, and help reps navigate increasingly complex buying committees. And on paper, it works. But like most things, in practice, it's more complicated. Despite investing months rolling out MEDDIC, many organizations soon discover that forecast accuracy and deal wins don't improve as much as they'd hoped.
So, what’s going wrong?
In this article, we'll explore that question in detail, breaking down why so many MEDDIC rollouts fail in practice, where enterprise deals actually die despite teams claiming they're "running MEDDIC," and what sales leaders can do to turn the framework from a CRM exercise into a methodology that genuinely improves qualification, forecasting, and win rates.
At its core, MEDDIC isn't a CRM checklist. It's a qualification methodology designed to help sales teams reduce uncertainty by gathering evidence throughout the buying process. Rather than relying on assumptions or optimism, it encourages reps to validate what they know at every stage of the deal.
Each of the 6 MEDDIC components exist to prevent a specific qualification risk:
Unfortunately, many organizations implement MEDDIC as documentation rather than a way of selling. The unintended consequence is that qualification becomes an administrative exercise instead of an ongoing process. Required fields are added to Salesforce, reps complete them as opportunities progress, and managers review whether each field has been populated rather than whether the information has been validated.
If your team measures MEDDIC adoption by CRM completion rates, you're probably measuring the wrong thing. A filled-in field doesn't prove an opportunity has been qualified, and it certainly doesn't mean a deal is healthy. Real adoption shows up in how reps discover, validate, and coach opportunities, not in how many required fields have been completed.
The result is a false sense of confidence. Opportunities appear qualified because every field has been populated, but the evidence behind them is often weak or outdated. Forecasts become less reliable, deals fall through the cracks unexpectedly, and leadership loses visibility into the enterprise opportunities that matter most.
Key takeaways:
Now that’s talk about the top 5 reasons why enterprise deals die, despite using the MEDDIC framework.
How many times have you seen an Economic Buyer listed in Salesforce, only to realize the rep has never actually had a conversation with them?
Knowing someone's title isn't the same as validating their role in the buying decision. Reps often assume budget authority based on an org chart or information shared by another stakeholder, only to discover late in the sales cycle that someone else controls the investment.
For example, let’s say a rep lists the CFO as the Economic Buyer because their director mentioned, "She'll sign off if we move forward." Three months later, procurement requests a meeting with the VP of Operations, who ultimately owns the budget but unfortunately, because the rep never validated who controls the investment, the deal stalls.
This is one of the easiest qualification gaps to miss because the information isn't necessarily wrong, it could just be outdated.
For example, if during the discovery process, the buyer tells your rep that ease of implementation is their top priority. And then two months later, IT and Security join the evaluation, and security certifications become the deciding factor. Because the rep never revisited the Decision Criteria, every demo and proposal continued emphasizing implementation speed instead of addressing the concerns that now mattered most.
The takeaway here is that decision criteria aren’t static. As new stakeholders join the buying committee, competitors enter the evaluation, or business priorities shift, the criteria buyers use to evaluate solutions often changes as well. Reps who document it once and never revisit it risk selling to yesterday's priorities instead of today's.
Many reps can describe how they think a deal will close. Far fewer can describe how the customer says it will close.
Let’s look at this in action. Imagine a rep forecasts a deal to close by the end of the month because the champion says they’re ready to move forward. But what the rep didn’t uncover was what the decision process involves, which in this case requires a security review followed by a legal review, adding another six weeks to the timeline
Enterprise deals rarely follow a predictable path. Procurement, legal, security reviews, executive approvals, and budget cycles all introduce complexity. When reps assume the process instead of validating it, opportunities often stall for reasons no one anticipated.
Generic pain creates generic deals.
For example, if a prospect says they want to "improve efficiency,” but the rep doesn’t dig deeper behind the meaning of this, they’ll miss the real pain behind the answer. In this case, perhaps the issue is that manual processes are costing the operations team nearly 20 hours each week and delaying customer onboarding. Without quantifying the problem, there's little urgency to solve it.
Statements like, "They want to save money," or "They're trying to be more efficient," aren't good enough. Strong discovery needs to uncover a specific business problem, quantify its impact, and identify who owns it.
Reason #5: The Champion Was Never Proven
Responding to emails, taking your calls, or expressing enthusiasm about your product doesn't make someone a Champion.
It's easy for reps to mistake engagement for influence, but the two aren't the same. A true Champion doesn't just like your solution. They advocate for it when you're not in the room, introduce you to key stakeholders, share valuable internal information, and actively help move the opportunity forward.
But the bottom line is, Champions aren’t identified through opinion, they’re validated through action.
By now, you're probably wondering, "If these qualification gaps are so common, why aren't they being caught sooner?" It's a fair question.
The problem is that many deal reviews focus on whether MEDDIC exists rather than whether it's being used as intended. Managers ask questions like, "Do you have a Champion?" or "Have you identified the Economic Buyer?" and accept a simple "yes" or the name of an individual without asking for the evidence behind the answer.
As a result, assumptions go unchallenged, qualification gaps remain hidden, and risky opportunities continue moving through the pipeline as if they're healthy.
To avoid this trap, managers need to ask pointed questions that require proof. Examples include:
Those follow-up questions reveal what a CRM field can’t, and turn deal reviews into valuable coaching opportunities rather than surface-level pipeline updates.
No one sets out to turn MEDDIC into a checkbox exercise, but that's often exactly what happens.
As Salesforce fields become required, validation rules are added, and opportunities can't advance until every section of MEDDIC has been completed, the focus naturally shifts toward CRM hygiene. While this may improve data completeness, it doesn't necessarily improve qualification or accuracy.
Before long, reps learn that success is measured by completing fields rather than validating information. The priority becomes filling in every box before the next pipeline review instead of asking better discovery questions and continuously testing what they know about the opportunity.
To avoid this trap:
When evidence becomes the priority, the CRM becomes more accurate, forecasts become more reliable, and MEDDIC works as intended.
A rep who talks about MEDDIC can tell you what each letter stands for. They know how to complete every Salesforce field and can confidently answer whether they've identified the Economic Buyer, Champion, or Decision Criteria.
A rep who has adopted MEDDIC approaches discovery differently. They're constantly validating assumptions, asking follow-up questions, revisiting information as the deal evolves, and looking for evidence before advancing an opportunity.
A rep who talks about MEDDIC might ask:
A rep who has adopted MEDDIC stays curious, and asks deeper, more probing questions:
The first rep is collecting answers and accepting them as true. The second is gathering the evidence needed to build a compelling business case for change.
If MEDDIC has become a documentation exercise at your organization, the solution isn’t to throw it out — it’s to change how it’s coached, measured, and reinforced.
In this section, we’ll walk you through a few practical ways to get your team back on track.
The easiest way to tell whether MEDDIC has truly been adopted is to observe how reps sell, not how they document. Instead of relying on Salesforce fields alone, look for evidence that MEDDIC is shaping customer conversations.
For example:
MEDDIC should shape customer conversations long before it shows up in Salesforce.
Instead of reminding reps to fill in fields, encourage them to gather the evidence needed to answer them confidently. During call preparation, discuss which MEDDIC components still need validation. During call debriefs, review what was learned, what assumptions changed, and what still needs to be confirmed.
Another helpful coaching technique is to simplify the framework. Rather than expecting reps to memorize dozens of qualification questions, give them two or three high-impact questions for each MEDDIC component that they can naturally incorporate into discovery conversations.
Reps naturally focus on what managers inspect and reward.
If deal reviews revolve around CRM completion, reps will optimize for completed fields. If coaching focuses on evidence, validation, and honest qualification, those behaviors will become the standard instead.
One of the simplest changes managers can make is replacing status updates with evidence-based coaching.
Also, make sure you regularly recognize reps who identify risk early, even if it means downgrading an opportunity or pushing out a forecast. Honest qualification leads to healthier pipelines, more reliable forecasts, and better long-term performance than optimistic reporting ever will.
No qualification framework is one-size-fits-all. As you think about how MEDDIC fits into your sales organization, there are a few additional considerations worth keeping in mind:
Many frontline managers were never coached to ask evidence-based qualification questions themselves. As a result, they default to reviewing pipeline status instead of validating opportunity health. If managers aren't reinforcing MEDDIC through coaching, it's difficult to expect reps to apply it consistently.
When reps consistently validate assumptions, revisit qualification throughout the sales cycle, and honestly assess deal risk, pipeline reviews become more accurate, coaching becomes more effective, and forecasts become more reliable.
MEDDIC doesn't fail because the framework is flawed. It fails when organizations measure documentation instead of behavior, rewarding completed CRM fields over validated evidence.
Rather than using MEDDIC as a checklist, coach your reps to use it to improve discovery, challenge assumptions, and continuously qualify opportunities as deals evolve. If you make one change this week, start asking your reps to prove what they know instead of simply telling you they know it.
